ClinConnect ClinConnect Logo
Search / Trial NCT05074849

Benefits of Insoles With Real-Time Alert and Foot Self-Care Education

Launched by TEXAS WOMAN'S UNIVERSITY · Sep 29, 2021

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help people with diabetes take better care of their feet and prevent serious foot problems, like ulcers. The researchers are testing special insoles that work with a smartwatch to give real-time alerts and reminders about foot care. Along with this technology, participants will receive education on how to properly care for their feet while wearing their prescribed diabetic footwear. The goal is to encourage patients to use their footwear more consistently and reduce the risk of foot ulcers, which can be a common complication for those living with diabetes.

To be eligible for this trial, participants should be at least 18 years old, have a diagnosis of diabetes, and currently use prescribed footwear for their condition. They should also be able to attend follow-up appointments, even if that means traveling a bit. However, individuals with certain serious foot issues, recent heart or lung problems, infections, or significant cognitive difficulties will not be included in the study. If you join the trial, you can expect to use the new insoles and smartwatch, attend educational sessions, and have regular check-ins to monitor your progress and foot health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Men or women 18 years old or older,
  • Diagnosis of Diabetes Mellitus,
  • Ambulatory, Uses prescribed diabetes footwear.
  • Those willing and able to attend follow up visits such as long distance (i.e. greater than 30 miles to recruitment sites).
  • Those able to read or follow directions.
  • Exclusion Criteria:
  • Active Charcot Arthropathy or major foot deformity,
  • Cardiopulmonary disease (e.g. recent MI, Stroke),
  • Gangrene, active infection. Montreal Cognitive Assessment (MOCA\<20).
  • Wide spread malignancy or systemically immunocompromising disease.

About Texas Woman's University

Texas Woman's University (TWU) is a leading institution dedicated to advancing health and wellness through innovative research and education. As a prominent clinical trial sponsor, TWU leverages its expertise in various fields, particularly in women's health, to design and conduct rigorous clinical studies that contribute to evidence-based practices and improved patient outcomes. Committed to ethical standards and community engagement, TWU collaborates with healthcare professionals and researchers to explore critical health issues, ultimately aiming to enhance the quality of life for diverse populations.

Locations

Houston, Texas, United States

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Ngozi Mbue

Principal Investigator

Texas Woman's University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials